Chemoinformaics analysis of 4-Beta-D-Glucopyranosyloxybenzyl-Alcohol
Molecular Weight | 286.28 | nRot | 4 |
Heavy Atom Molecular Weight | 268.136 | nRig | 12 |
Exact Molecular Weight | 286.105 | nRing | 2 |
Solubility: LogS | -1.272 | nHRing | 1 |
Solubility: LogP | -1.512 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
nHA | 7 | APOL | 39.3263 |
nHD | 5 | BPOL | 21.5297 |
QED | 0.45 |
Synth | 3.321 |
Natural Product Likeliness | 1.795 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.018 |
HIA | 0.823 |
CACO-2 | -5.386 |
MDCK | 0.000411957 |
BBB | 0.538 |
PPB | 0.206887 |
VDSS | 0.414 |
FU | 0.616369 |
CYP1A2-inh | 0.032 |
CYP1A2-sub | 0.038 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.242 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.081 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.316 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.038 |
CL | 1.699 |
T12 | 0.539 |
hERG | 0.044 |
Ames | 0.226 |
ROA | 0.049 |
SkinSen | 0.048 |
Carcinogencity | 0.693 |
EI | 0.021 |
Respiratory | 0.014 |
NR-Aromatase | 0.025 |
Antiviral | Yes |
Prediction | 0.824056 |